138 related articles for article (PubMed ID: 29228628)
1. Drug sensitivity profiling identifies potential therapies for lymphoproliferative disorders with overactive JAK/STAT3 signaling.
Kuusanmäki H; Dufva O; Parri E; van Adrichem AJ; Rajala H; Majumder MM; Yadav B; Parsons A; Chan WC; Wennerberg K; Mustjoki S; Heckman CA
Oncotarget; 2017 Nov; 8(57):97516-97527. PubMed ID: 29228628
[TBL] [Abstract][Full Text] [Related]
2. [Large Granular Lymphocytic Leukemia and JAK/STAT Signaling Pathway--Review].
Qiu ZY; Fan Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):254-60. PubMed ID: 26913432
[TBL] [Abstract][Full Text] [Related]
3. An activated JAK/STAT3 pathway and CD45 expression are associated with sensitivity to Hsp90 inhibitors in multiple myeloma.
Lin H; Kolosenko I; Björklund AC; Protsyuk D; Österborg A; Grandér D; Tamm KP
Exp Cell Res; 2013 Mar; 319(5):600-11. PubMed ID: 23246572
[TBL] [Abstract][Full Text] [Related]
4. SD-1029 inhibits signal transducer and activator of transcription 3 nuclear translocation.
Duan Z; Bradner JE; Greenberg E; Levine R; Foster R; Mahoney J; Seiden MV
Clin Cancer Res; 2006 Nov; 12(22):6844-52. PubMed ID: 17121906
[TBL] [Abstract][Full Text] [Related]
5. Mutations in the signal transducer and activator of transcription family of genes in cancer.
Shahmarvand N; Nagy A; Shahryari J; Ohgami RS
Cancer Sci; 2018 Apr; 109(4):926-933. PubMed ID: 29417693
[TBL] [Abstract][Full Text] [Related]
6. 8-benzyl-4-oxo-8-azabicyclo[3.2.1]oct-2-ene-6,7-dicarboxylic acid (SD-1008), a novel janus kinase 2 inhibitor, increases chemotherapy sensitivity in human ovarian cancer cells.
Duan Z; Bradner J; Greenberg E; Mazitschek R; Foster R; Mahoney J; Seiden MV
Mol Pharmacol; 2007 Nov; 72(5):1137-45. PubMed ID: 17675586
[TBL] [Abstract][Full Text] [Related]
7. Uncovering the pathogenesis of large granular lymphocytic leukemia-novel STAT3 and STAT5b mutations.
Rajala HL; Porkka K; Maciejewski JP; Loughran TP; Mustjoki S
Ann Med; 2014 May; 46(3):114-22. PubMed ID: 24512550
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression.
Epling-Burnette PK; Liu JH; Catlett-Falcone R; Turkson J; Oshiro M; Kothapalli R; Li Y; Wang JM; Yang-Yen HF; Karras J; Jove R; Loughran TP
J Clin Invest; 2001 Feb; 107(3):351-62. PubMed ID: 11160159
[TBL] [Abstract][Full Text] [Related]
9. Effect of the JAK2/STAT3 inhibitor SAR317461 on human glioblastoma tumorspheres.
Mukthavaram R; Ouyang X; Saklecha R; Jiang P; Nomura N; Pingle SC; Guo F; Makale M; Kesari S
J Transl Med; 2015 Aug; 13():269. PubMed ID: 26283544
[TBL] [Abstract][Full Text] [Related]
10. Loss of function mutations in PTPN6 promote STAT3 deregulation via JAK3 kinase in diffuse large B-cell lymphoma.
Demosthenous C; Han JJ; Hu G; Stenson M; Gupta M
Oncotarget; 2015 Dec; 6(42):44703-13. PubMed ID: 26565811
[TBL] [Abstract][Full Text] [Related]
11. Whole Genome Sequencing of Spontaneously Occurring Rat Natural Killer Large Granular Lymphocyte Leukemia Identifies JAK1 Somatic Activating Mutation.
Wang TT; Yang J; Dighe S; Schmachtenberg MW; Leigh NT; Farber E; Onengut-Gumuscu S; Feith DJ; Ratan A; Loughran TP; Olson TL
Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31947841
[TBL] [Abstract][Full Text] [Related]
12.
Muñoz-García N; Jara-Acevedo M; Caldas C; Bárcena P; López A; Puig N; Alcoceba M; Fernández P; Villamor N; Flores-Montero JA; Gómez K; Lemes MA; Hernández JC; Álvarez-Twose I; Guerra JL; González M; Orfao A; Almeida J
Cancers (Basel); 2020 Nov; 12(12):. PubMed ID: 33255665
[No Abstract] [Full Text] [Related]
13. Emergence of a STAT3 mutated NK clone in LGL leukemia.
Yan Y; Olson TL; Nyland SB; Feith DJ; Loughran TP
Leuk Res Rep; 2015; 4(1):4-7. PubMed ID: 25709890
[TBL] [Abstract][Full Text] [Related]
14. The JAK-inhibitor, JAB/SOCS-1 selectively inhibits cytokine-induced, but not v-Src induced JAK-STAT activation.
Iwamoto T; Senga T; Naito Y; Matsuda S; Miyake Y; Yoshimura A; Hamaguchi M
Oncogene; 2000 Sep; 19(41):4795-801. PubMed ID: 11032030
[TBL] [Abstract][Full Text] [Related]
15. JAK2 V617F is a rare finding in de novo acute myeloid leukemia, but STAT3 activation is common and remains unexplained.
Steensma DP; McClure RF; Karp JE; Tefferi A; Lasho TL; Powell HL; DeWald GW; Kaufmann SH
Leukemia; 2006 Jun; 20(6):971-8. PubMed ID: 16598306
[TBL] [Abstract][Full Text] [Related]
16. Selective drug combination vulnerabilities in STAT3- and TP53-mutant malignant NK cells.
Parri E; Kuusanmäki H; Bulanova D; Mustjoki S; Wennerberg K
Blood Adv; 2021 Apr; 5(7):1862-1875. PubMed ID: 33792631
[TBL] [Abstract][Full Text] [Related]
17. Large Granular Lymphocytic Leukemia: Clinical Features, Molecular Pathogenesis, Diagnosis and Treatment.
Ullah F; Markouli M; Orland M; Ogbue O; Dima D; Omar N; Mustafa Ali MK
Cancers (Basel); 2024 Mar; 16(7):. PubMed ID: 38610985
[TBL] [Abstract][Full Text] [Related]
18. Physalin A exerts anti-tumor activity in non-small cell lung cancer cell lines by suppressing JAK/STAT3 signaling.
Zhu F; Dai C; Fu Y; Loo JF; Xia D; Gao SP; Ma Z; Chen Z
Oncotarget; 2016 Feb; 7(8):9462-76. PubMed ID: 26843613
[TBL] [Abstract][Full Text] [Related]
19. Novel JAK3-Activating Mutations in Extranodal NK/T-Cell Lymphoma, Nasal Type.
Sim SH; Kim S; Kim TM; Jeon YK; Nam SJ; Ahn YO; Keam B; Park HH; Kim DW; Kim CW; Heo DS
Am J Pathol; 2017 May; 187(5):980-986. PubMed ID: 28284718
[TBL] [Abstract][Full Text] [Related]
20. Cell density dependent increase of constitutive signal transducers and activators of transcription 3 activity in melanoma cells is mediated by Janus kinases.
Kreis S; Munz GA; Haan S; Heinrich PC; Behrmann I
Mol Cancer Res; 2007 Dec; 5(12):1331-41. PubMed ID: 18171991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
